EXCHANGE AGREEMENT by and among Protalix BioTherapeutics, Inc. and the Parties Signatory Hereto Dated as of August 12, 2021Exchange Agreement • August 13th, 2021 • Protalix BioTherapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 13th, 2021 Company Industry JurisdictionEXCHANGE AGREEMENT dated as of August 12, 2021 (this “Agreement”), by and among Protalix BioTherapeutics, Inc., a Delaware corporation (the “Company”), and the parties signatory hereto (each, a “Purchaser,” and collectively, the “Purchasers”).
EXCHANGE AGREEMENT by and among Protalix BioTherapeutics, Inc. and the Parties Signatory Hereto Dated as of July 24, 2017Exchange Agreement • July 25th, 2017 • Protalix BioTherapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJuly 25th, 2017 Company Industry JurisdictionEXCHANGE AGREEMENT dated as of July 24, 2017 (this “Agreement”), by and among Protalix BioTherapeutics, Inc., a Delaware corporation (the “Company”), and the parties signatory hereto (each, a “Purchaser,” and collectively, the “Purchasers”).
FORM OF EXCHANGE AGREEMENT by and among Protalix BioTherapeutics, Inc. and the Parties Signatory Hereto Dated as of December 1, 2016Exchange Agreement • December 7th, 2016 • Protalix BioTherapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledDecember 7th, 2016 Company Industry JurisdictionEXCHANGE AGREEMENT dated as of December 1, 2016 (this “Agreement”), by and among Protalix BioTherapeutics, Inc., a Delaware corporation (the “Company”), and the parties signatory hereto (each, a “Purchaser,” and collectively, the “Purchasers”).